A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)

Clinical trial NCT00290550 · TERMINATED

Trial details

NCT number: NCT00290550
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2006-06-01
Primary completion: 2007-05-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.